BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26463672)

  • 1. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
    Vijayakrishnan J; Henrion M; Moorman AV; Fiege B; Kumar R; da Silva Filho MI; Holroyd A; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Bartram CR; Schrappe M; Greaves M; Hemminki K; Harrison CJ; Stanulla M; Houlston RS
    Sci Rep; 2015 Oct; 5():15065. PubMed ID: 26463672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.
    Walsh KM; de Smith AJ; Hansen HM; Smirnov IV; Gonseth S; Endicott AA; Xiao J; Rice T; Fu CH; McCoy LS; Lachance DH; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR; Ma X; Metayer C; Wiemels JL
    Cancer Res; 2015 Nov; 75(22):4884-94. PubMed ID: 26527286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
    Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.
    Vijayakrishnan J; Kumar R; Henrion MY; Moorman AV; Rachakonda PS; Hosen I; da Silva Filho MI; Holroyd A; Dobbins SE; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Heilmann-Heimbach S; Jöckel KH; Greaves M; Harrison CJ; Bartram CR; Schrappe M; Stanulla M; Hemminki K; Houlston RS
    Leukemia; 2017 Mar; 31(3):573-579. PubMed ID: 27694927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia.
    Zhou X; Liao F; Zhang J; Qin Y; Xu H; Ding Z; Zhang Y; Zhang F
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
    Xu H; Zhang H; Yang W; Yadav R; Morrison AC; Qian M; Devidas M; Liu Y; Perez-Andreu V; Zhao X; Gastier-Foster JM; Lupo PJ; Neale G; Raetz E; Larsen E; Bowman WP; Carroll WL; Winick N; Williams R; Hansen T; Holm JC; Mardis E; Fulton R; Pui CH; Zhang J; Mullighan CG; Evans WE; Hunger SP; Gupta R; Schmiegelow K; Loh ML; Relling MV; Yang JJ
    Nat Commun; 2015 Jun; 6():7553. PubMed ID: 26104880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
    Sattarzadeh Bardsiri M; Zehtab S; Karami N; Farsinejad A; Ehsan M; Fatemi A
    BMC Med Genomics; 2022 Aug; 15(1):171. PubMed ID: 35932035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
    Pastorczak A; Górniak P; Sherborne A; Hosking F; Trelińska J; Lejman M; Szczepański T; Borowiec M; Fendler W; Kowalczyk J; Houlston RS; Młynarski W
    Leuk Res; 2011 Nov; 35(11):1534-6. PubMed ID: 21889209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
    Sherborne AL; Hosking FJ; Prasad RB; Kumar R; Koehler R; Vijayakrishnan J; Papaemmanuil E; Bartram CR; Stanulla M; Schrappe M; Gast A; Dobbins SE; Ma Y; Sheridan E; Taylor M; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Moorman AV; Harrison CJ; Tomlinson IP; Richards S; Zimmermann M; Szalai C; Semsei AF; Erdelyi DJ; Krajinovic M; Sinnett D; Healy J; Gonzalez Neira A; Kawamata N; Ogawa S; Koeffler HP; Hemminki K; Greaves M; Houlston RS
    Nat Genet; 2010 Jun; 42(6):492-4. PubMed ID: 20453839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
    Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
    Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia.
    Iacobucci I; Sazzini M; Garagnani P; Ferrari A; Boattini A; Lonetti A; Papayannidis C; Mantovani V; Marasco E; Ottaviani E; Soverini S; Girelli D; Luiselli D; Vignetti M; Baccarani M; Martinelli G
    Leuk Res; 2011 Aug; 35(8):1052-9. PubMed ID: 21414664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population.
    Gutierrez-Camino A; Martin-Guerrero I; Garcia de Andoin N; Sastre A; Carbone Bañeres A; Astigarraga I; Navajas A; Garcia-Orad A
    PLoS One; 2017; 12(5):e0177421. PubMed ID: 28481918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma.
    Osman W; Low SK; Takahashi A; Kubo M; Nakamura Y
    Hum Mol Genet; 2012 Jun; 21(12):2836-42. PubMed ID: 22419738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology.
    Hungate EA; Vora SR; Gamazon ER; Moriyama T; Best T; Hulur I; Lee Y; Evans TJ; Ellinghaus E; Stanulla M; Rudant J; Orsi L; Clavel J; Milne E; Scott RJ; Pui CH; Cox NJ; Loh ML; Yang JJ; Skol AD; Onel K
    Nat Commun; 2016 Feb; 7():10635. PubMed ID: 26868379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the Framingham heart study.
    Johnson AD; Hwang SJ; Voorman A; Morrison A; Peloso GM; Hsu YH; Thanassoulis G; Newton-Cheh C; Rogers IS; Hoffmann U; Freedman JE; Fox CS; Psaty BM; Boerwinkle E; Cupples LA; O'Donnell CJ
    Circulation; 2013 Feb; 127(7):799-810. PubMed ID: 23315372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
    Congrains A; Kamide K; Oguro R; Yasuda O; Miyata K; Yamamoto E; Kawai T; Kusunoki H; Yamamoto H; Takeya Y; Yamamoto K; Onishi M; Sugimoto K; Katsuya T; Awata N; Ikebe K; Gondo Y; Oike Y; Ohishi M; Rakugi H
    Atherosclerosis; 2012 Feb; 220(2):449-55. PubMed ID: 22178423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
    Brown AL; de Smith AJ; Gant VU; Yang W; Scheurer ME; Walsh KM; Chernus JM; Kallsen NA; Peyton SA; Davies GE; Ehli EA; Winick N; Heerema NA; Carroll AJ; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Feingold E; Devidas M; Barcellos LF; Hansen HM; Morimoto L; Kang AY; Smirnov I; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson P; Spector LG; Pombo-de-Oliveira MS; DeWan AT; Mullighan CG; Hunger SP; Pui CH; Loh ML; Zwick ME; Metayer C; Ma X; Mueller BA; Sherman SL; Wiemels JL; Relling MV; Yang JJ; Lupo PJ; Rabin KR
    Blood; 2019 Oct; 134(15):1227-1237. PubMed ID: 31350265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
    Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
    Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood.
    Novara F; Beri S; Bernardo ME; Bellazzi R; Malovini A; Ciccone R; Cometa AM; Locatelli F; Giorda R; Zuffardi O
    Hum Genet; 2009 Oct; 126(4):511-20. PubMed ID: 19484265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common genetic variants in the 9p21 region and their associations with multiple tumours.
    Gu F; Pfeiffer RM; Bhattacharjee S; Han SS; Taylor PR; Berndt S; Yang H; Sigurdson AJ; Toro J; Mirabello L; Greene MH; Freedman ND; Abnet CC; Dawsey SM; Hu N; Qiao YL; Ding T; Brenner AV; Garcia-Closas M; Hayes R; Brinton LA; Lissowska J; Wentzensen N; Kratz C; Moore LE; Ziegler RG; Chow WH; Savage SA; Burdette L; Yeager M; Chanock SJ; Chatterjee N; Tucker MA; Goldstein AM; Yang XR
    Br J Cancer; 2013 Apr; 108(6):1378-86. PubMed ID: 23361049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.